Skip to main content

Impact of community and provider-driven social accountability interventions on contraceptive uptake in Ghana and Tanzania



Social accountability, which is defined as a collective process for holding duty bearers and service providers to account for their actions, has shown positive outcomes in addressing the interrelated barriers to quality sexual and reproductive health services. The Community and Provider driven Social Accountability Intervention (CaPSAI) Project contributes to the evidence on the effects of social accountability processes in the context of a family planning and contraceptive programme.


A quasi-experimental study utilizing an interrupted time series design with a control group (ITS-CG) was conducted to determine the actual number of new users of contraception amongst women 15–49 years old in eight intervention and eight control facilities per country in Ghana and Tanzania. A standardized facility audit questionnaire was used to collect facility data and completed every year in both intervention and control groups in each country from 2018–2020.


In Ghana, the two-segmented Poisson Generalized Estimating Equation (GEE) model demonstrated no statistically significant difference at post-intervention, between the intervention and control facilities, in the level of uptake of contraceptives (excess level) (p-value = 0.07) or in the rate of change (excess rate) in uptake (p-value = 0.07) after adjusting for baseline differences. Similarly, in Tanzania, there was no statistical difference between intervention and control facilities, in the level of uptake of contraceptives (excess level) (p-value = 0.20), with the rate of change in uptake (p-value = 0.05) after adjusting for the baseline differences. There was no statistical difference in the level of or rate of change in uptake in the two groups in a sensitivity analysis excluding new users recruited in outreach activities in Tanzania.


The CAPSAI project intervention did not result in a statistically significant increase in uptake of contraceptives as measured by the number of or increase in new users. In evaluating the impact of the intervention on the intermediate outcomes such as self-efficacy among service users, trust and countervailing power among social groups/networks, and responsiveness of service providers, cases of change and process evaluation should be considered.

Trial registration

The CaPSAI Project has been registered at the Australian New Zealand Clinical Trials Registry (ACTRN12619000378123, 11/03/2019).


Interventions for improving family planning and contraceptive service provision and access can contribute towards the attainment of Sustainable Development Goal 3.7 to ensure universal access to sexual and reproductive health care services, including family planning, information and education, and the integration of reproductive health into national strategies and programmes [1, 2]. Recent estimates show an increase in contraceptive use globally [1, 3]. Low- and middle-income countries (LMIC) have a disproportionately higher unmet need for modern contraception (approximately 218 million women 15–49 years of age), contributing to high rates of unintended pregnancies [1]. Young women aged 15–19 years in LMIC are more likely to have an unmet need and unintended pregnancy. Among 300 million women aged 15–19 years in 2019, 29.8 million currently use contraception, and 15.0 million have an unmet need [4]. Among adolescents, approximately 50% of 21 million pregnancies each year are unintended [1].

The reasons for the high unmet need among women in LMIC vary. They include women's socio-economic status, the lack of access to services, concerns about their health or method side effects, and opposition from a family member [1, 5]. Adolescents face numerous barriers in obtaining and receiving contraceptive care, including fear of exposing that they are sexually active (if they are unmarried) and social pressure to have a child (if they are married) [1]. Provider bias or unwillingness to provide contraceptive care to young unmarried and childless women is another barrier that is often cited [1].

Global guidance and strategies recommend that communities and people directly affected must have the opportunity to be meaningfully engaged in all aspects of family planning and contraceptive programme and policy design, implementation, and monitoring in order to achieve progress towards international development goals and sexual and reproductive health and rights (SRHR) targets [6, 7]. Integrating participation in family planning and contraceptive service provision ensures a rights-based approach to service provision and could better address women's contraceptive needs [6].

Social accountability (SA) is among the participatory processes gaining attention and showing positive outcomes in addressing the numerous and interrelated barriers to reproductive, maternal, newborn, and child and adolescent health (RMNCAH), including family planning and contraceptive service provision [8,9,10]. Although there is no consensus on the definition of SA in the literature, common elements have been identified [8]. At its core, and for the purpose of this manuscript, SA is defined as citizen-led collective processes for holding duty bearers, including politicians, government officials, and/or service providers, to account for their actions [11].

Positive findings regarding the effect of SA processes on RMNCAH, especially in service delivery and governance outcomes, and some health outcomes are growing ([8] and Appendix). However, specific evidence on SA applied to family planning, and contraceptive service provision remains limited. A 2016 review exploring activities that explicitly engage community members to improve RMNCAH found very little and poor-quality evidence for effects on family planning or birth spacing outcomes [12]. There are recent studies (Appendix) focusing on family planning and contraceptive services that reported positive outcomes, such as improvements in service quality, financial allocation for contraceptive service provision [13, 14], and community awareness [15,16,17] and participation [13, 14]. Studies have also reported increases in the current use of modern contraceptives [18] and the acceptability of providing family planning to adolescents [19].

A possible reason for the lack of family planning and contraceptive service-related studies could be the belief among programme implementers that family planning is more appropriately addressed through interventions targeting individuals or couples and not through community or public platforms [12].

The Community and Provider driven Social Accountability (CaPSAI) Project contributes to the evidence on the effects of SA and participatory processes in the context of family planning and contraceptive programmes. The study was designed according to the Medical Research Council (MRC) guidance on complex interventions based on a theory of change (ToC) (Fig. 1) using a co-designed intervention to account for the complexity of SA processes [20,21,22,23]. It accounts for the multiple components required to track the different levels and interrelated outcomes and includes a process evaluation component [20].

Fig. 1
figure 1

CaPSAI Project Theory of Change – adapted with permission from Steynn 2020 [20]. Image by Little Unicorns

The CaPSAI Project ToC (Fig. 1) was developed after a review of the literature and findings from the formative phase research [10, 20, 24]. Firstly, the descriptions, evidence, and programme report from SA interventions applied to health were gathered to understand the common steps being used [9]. Eight steps, which served as a foundation of the intervention, were identified (Fig. 1). The CaPSAI ToC anticipates that engaging community members and health system actors to identify challenges in family planning and contraceptive service provision and develop action plans can lead to improved quality of services, counseling, interpersonal care, staff capacity, and stock management [20]. These, in turn, were expected to facilitate increased uptake and use of modern contraceptive methods by supporting full, free, and informed choice. The CaPSAI ToC is based on several assumptions, including the existence of enabling legal and policy environments for participatory processes and contraceptive use and the ability and willingness of community members and health providers to dialogue on issues related to SRHR.

The study's overall aim is to demonstrate if and how a SA process in the context of family planning and contraceptive programs/services influences quality of care and client satisfaction and whether this results in increased contraceptive uptake and use. Specifically, it aimed to (i) describe and examine how SA processes are implemented and operationalized (understanding behaviours, decision-making processes, and the barriers and facilitators of change, with a view to generalizability); and to (ii) develop more responsive quantitative measures for SA and show the relationship between SA and uptake of contraceptives and use and other family planning behaviours (Table 1).

Table 1 Study overview

This manuscript will report on the contraceptive uptake outcome measured by the number of new users from a series of facility audits. Other outcomes mentioned in the background section will be reported in separate manuscripts (Table 1).



In the context of the CaPSAI study, two civil society organizations (CSO) implementing SA processes that included the eight steps of the ToC were selected from Ghana and Tanzania [21]. To embed the study intervention in local contextual realities CSO partner routines and to account for the processual nature of SA, the study did not define intervention activities prescriptively (Table 2). Instead, the intervention was co-designed with the implementing partners and used conceptual fidelity where the interventions were tracked, comparing the intended activities and how they were implemented [21].

Table 2 Eight standard steps of Community and Health Provider driven Social Accountability Intervention (CaPSAI) – reproduced with permission from Steyn 2020 [20]

Study design

A quasi-experimental study utilizing an interrupted time series design with a control group (ITS-CG) was conducted to determine the actual number of new users of contraception amongst women 15–49 years old in eight intervention and eight control facilities per country in Ghana and Tanzania during 18 months. A detailed description of the ITS-CG design has been published elsewhere [25].

Main outcomes

The primary outcome of the study, uptake of modern contraception, is defined as the rate of first-time modern contraception users, expressed as the number of women in the study facilities requesting the use of modern contraception for the first time per month, per 10,000 women of reproductive age, in the catchment area.

Study setting

Site selection is discussed in detail in a protocol manuscript and the Australian New Zealand Clinical Trials Registry and summarised here [20, 26]. Ghana and Tanzania were selected as the study countries because they had: the presence of an active CSO partner with local experience in delivering a SA intervention with the eight steps referred to above (Table 2); low modern contraceptive prevalence (mCPR) rate, excluding barrier contraception; availability of contraceptive services to the client at no cost or where cost was not a barrier to access. Other criteria included an enabling environment for the health system to act on SA activities and the existence of established structures to link the community with the health system [20, 26].

In Ghana, mCPR increased from 18.7% in 2003 [27] to 22.2% in 2014 and to 25.0% in 2017 [28] among currently married women. Among all women, it increased from 15.3% in 2003 [27] to 18.2 in 2014 [29] and then to 19.5 in 2017 [28]. Unmet need, marginally decreased from 34.0% in 2003 [27] to 29.9% in 2014 [29] and increased to 33.6% in 2017 [30].

The Ghana health system structure includes three main levels of health service provision: primary (health centres, clinics, and Community-based Health Planning and Services, known as CHPS), secondary (district and regional hospitals), and tertiary (teaching hospitals, with the Ministry of Health as the overarching body overseeing the health system and the Ghana Health Service as the implementing branch). Family planning and contraceptive services are provided at all levels of health service provision.

In Tanzania, the mCPR rate is at 28.9% despite a steady increase over the past decade, from 18% in 2004 [31]. Among currently married women, injectables (8.5%), pills (5.1%), and male condoms (4.2%) are the most used. Contraceptive use varies according to background characteristics, with married women in urban areas being more likely to use a modern method than rural women. The government or the public sector is the main source of modern methods (65% of users) [31, 32].

The Tanzanian health service delivery is categorized into three levels: primary care, secondary, and tertiary care. The primary care level consists of dispensaries that only provide outpatient care and refer complicated cases to the secondary care level. The secondary level consists of health centres and district hospitals that provide both outpatient and inpatient care. All complicated cases are referred to the tertiary level. The tertiary level includes regional referral hospitals and super-specialized hospitals. Family planning and contraceptive services are provided in all of the facilities at all levels.

Districts selected had no SA intervention in family planning and contraceptive programmes at baseline and sufficient health facilities offering family planning services. Data for at least 20 health facilities in the selected districts were used to select eight intervention and eight control facilities. Selected facilities had at least a barrier method, a short and long-acting method, emergency contraception, and referral for permanent methods available. The matching of study and control sites was done on the type and level of facilities, the average number of service users, and the number of new users. Facilities with the following characteristics were excluded: (i) a mean of less than 50 new users per month, (ii) private and NGO facilities, and (iii) tertiary or secondary and referral facilities.

The interventions were conducted in the intervention facility catchment areas, targeting community members, health professionals, and other duty bearers. Study outcomes were measured at the facility level, where we expected changes in uptake.

Sample size and statistical analysis

The detailed estimation of study sample size and power were done in two ways and described in Habib et al. [25] and Steyn et al. [20]. The facility was the unit of measurement used for Poisson regression, and the monthly data points were the unit of measurement for time series regression. At pre-intervention (or baseline) and at post-intervention, different sample size estimates were computed using a two-sided t-test with Type I error at 5% level, statistical power at 80%, and assuming equal variance [25]. These various sample size estimates provided assumed a constant denominator and a pooled variance for the mean number of new users at pre-intervention in both groups of between 100 and 200 new users per facility, per month, and a difference in uptake per facility per month, at post-intervention of between 60 and 200 new users. From this, eight facilities per intervention or control group were chosen to detect about a two-fold increase in the rate of new users with 80% power and allowing for a 5% Type I error.

Using the monthly data points as the unit of analysis, we relied on the simulation-based power calculation provided by Zhang et al., 2011 taking effect size and time periods into account [33]. Assuming an effect size of 2.0 (derived from 100 new users in the control group and 200 new users in the intervention group and a pooled standard deviation of 50) and autocorrelation of up to 0.3, we would need a total of 12 data points. This is equivalent to six monthly pre-intervention data points and six-monthly post-intervention data points to achieve 80% power at a p = 0.05 statistical significance level [33].

As the facility was used as the unit of analysis, all potential confounders at the facility level were recorded. An ITS segmented Poisson regression model was used to estimate both the level changes in first-use of modern contraception rate and changes in time trends for the rate of modern contraception first-use rates per 10,000 women-months, after the introduction of the intervention. The generalized estimating equation (GEE) Poisson segmented regression model allowed for adjustment for correlation due to repeated observations from the same facilities while also adjusting for important baseline facility characteristics [20, 25, 26].

Data collection

A standardized questionnaire [34] was used for the facility audit and completed on a yearly basis in both control and intervention sites. This was done through interviews with facility staff, preferably a manager. The audit was adapted and shortened from the Service Availability and Readiness Assessment (SARA) tool [35]. The service statistics were continuously recorded, and the number of new users was determined by the facility staff and recorded monthly to minimize selection/performance bias. The research staff was trained to avoid misinterpretation of data and ensure that the outcome was assessed in a consistent manner. Data were double entered into a web-based OpenClinica® database and adhered to principles of data management as specified in the data management standard operating procedure [36].


The service statistics, which included the monthly number of new users, were collected in the eight study and eight control sites in the two countries from the facility staff and documentation. This was done for six months before the intervention to determine the baseline (March to April 2018), interim (March to April 2019), and at end line (March to April 2020). Adaptations to the data collection had to be made during the COVID-19 pandemic, which restricted in-person data gathering. This caused a delay in data gathering until May 2020 in Ghana. In Ghana, 31 months of data were collected from September 2017 to March 2020. In Tanzania, 31 months of data were collected from August 2017 to February 2020. The number of new contraceptive users per month, per study group, averaged across facilities over the study time is shown in Fig. 2 and Fig. 3 for Ghana and Tanzania, respectively.

Fig. 2
figure 2

Intervention and Control Facilities: Averaged contraceptive new user count over study time, by study group, Ghana

Fig. 3
figure 3

Intervention and Control Facilities: Averaged contraceptive new user count over study time, by study group, Tanzania


Facility characteristics at baseline for both countries

The facility characteristics at baseline for the respective countries are presented in Table 3. In Ghana, the type of facilities included in the control group were one district hospital, five health centres, one Community-based Health Planning and Services (CHPS), and one reproductive and child health clinic as compared to one district hospital, six health centres, one CHPS in the intervention group. In Tanzania, the type of facilities included in the control group were four health centres or clinics, four dispensaries against two health centres or clinics, and six dispensaries in the intervention group. In both countries, the managing authority for all facilities was the public health authority. All facilities have family planning and contraceptive services, which are offered for four to eight hours per day. In Ghana, contraceptive methods are free, but the services are not. In Tanzania, both contraceptive methods and services are free. Staff in all facilities in Ghana received specified family training during the previous two years, whereas seven facilities in the control group and five facilities in the intervention group in Tanzania received training in the previous two years. All intervention and control facilities in both countries met the inclusion criteria for the minimum types of methods provided. Most (15 of 16) facilities in both countries conducted various outreach programmes, including maternal, child, and newborn health care, in addition to family planning.

Table 3 General description of facilities in Ghana and Tanzania at baseline

Uptake in Ghana

In the control group, the number of first-time contraceptive users nine months before the intervention was 5278 and 7901 in the 17 months post-intervention. In the intervention group, it was 4659 at pre-intervention and 8743 at post-intervention. The numbers of first-time contraceptive users per month are shown in Fig. 4 (control group) and Fig. 5 (intervention group). Table 4 shows the two-segmented Poisson GEE model log uptake parameter estimates using all available 26 data points (9 pre- and 17 post-intervention). The model excludes the intervention roll-out phase of five months. For the control group, the pre-intervention rate of change in uptake was not significantly different from zero (p-value = 0.8). Post-intervention, the level and rate of change in uptake (p-value = 0.9) and (p-value = 0.2), respectively, were not significantly different from pre-intervention in the control group. When the pre-intervention study- and control groups were compared, the uptake levels and rate of change in uptake were not significantly different between the intervention (p-value = 0.8) and control facilities (p-value = 0.2). Post-intervention, the uptake level rate of change in uptake was not statistically significant different between intervention (p-value = 0.07); and control groups (p-value = 0.07) after adjusting for baseline differences.

Fig. 4
figure 4

The number of first-time contraceptive users per Control facility per month, Ghana

Fig. 5
figure 5

The number of first-time contraceptive users per Intervention facility per month, Ghana

Table 4 GHANA—Two-segmented Poisson GEE Model Log(Uptake) parameter estimates (AR[1] working correlation) using all available 26 datapoints (9 pre-, 17 post) (excluding intervention roll-out phase)

Uptake in Tanzania

In the control group, the number of first-time contraceptive users ten months before the intervention phase was 3454 and 13566 in the 16 months post-intervention. In the intervention group, it was 3766 in pre-intervention and 8138 in post-intervention. When outreach services were excluded from the control group, the number of first-time contraceptive users was 2180 at pre- and 6182 at post-intervention. In the control group, there were 3766 and 6511 first-time contraceptive users, respectively. The number of first-time contraceptive users per month is shown in Fig. 6 (Control group) and Fig. 7 (intervention group). Table 5 shows the two-segmented Poisson GEE model log uptake parameter estimates using 26 data points (10 at pre- and 16 at post-intervention). The model excludes the intervention roll-out phase of five months. For the control group, the pre-intervention rate of change in uptake was not significantly different from zero (p-value = 0.34). Post-intervention the uptake (p-value = 0.021) and (p-value = 0.94) respectively were not significantly different from pre-intervention in the control group. When the pre-intervention study and control groups were compared, the uptake levels were significantly lower than in the control group facilities (p-value = 0.016). However, the pre-intervention rate of change was not significantly different p-value = 0.66). Post-intervention, the difference in uptake level and rate of change in uptake were not statistically significant between the intervention(p-value = 0.053) and control groups (p-value = 0.053) after adjusting for baseline difference.

Fig. 6
figure 6

The number of first-time contraceptive users per Control facility per month, Tanzania

Fig. 7
figure 7

The number of first-time contraceptive users per Intervention facility per month, Tanzania

Table 5 Tanzania—Two-segmented Poisson GEE Model Log(Uptake) parameter estimates (AR(1) working correlation) using all available 26 datapoints (9 pre-, 17 post) (excluding intervention roll-out phase)

Sensitivity analysis

Two sensitivity analyses were done. Firstly, in Tanzania, outreach activities by non-governmental organizations were more frequent during specific months in the control facilities. New users from these outreach activities were added to the facilities' monthly data, although service provision, including the provision of commodities, was not done by the facility staff. Figure 8 shows the crude number of new users per month (excluding the outreach services) averaged over each control and intervention facility. In the GEE model, the exclusion of new users enrolled in outreach activities in intervention and control sites did not significantly change estimates of intervention effect (results not shown).

Fig. 8
figure 8

Intervention and Control Facilities: Averaged contraceptive new user count over study time, by study group, Tanzania – Excluding outreach activities

A second sensitivity analysis was done in both countries, including data from six months after the intervention during the follow-up meetings to monitor, support, and strengthen the identified prioritized actions. In Ghana, this did not significantly change estimates of the intervention effect. There were no significant changes in Tanzania when the outreach data were excluded (results not shown).


The study's overall aim is to demonstrate how a SA process in family planning and contraceptive programmes and services influences the quality of care and client satisfaction and whether this leads to increased contraceptive uptake and use. We report here on the relationship between SA and uptake of modern contraceptives.

In this ITS-CG, we did not find a statistically significant increase in uptake of contraceptives in the intervention compared to the control facilities as measured by the number of new users before and after the intervention. This finding is consistent with other recent studies, including two large-scale, randomized controlled trials that evaluated health outcomes in SA. The Accountability Can Transform Health (ACT Health) scaled up the Power to the People [37] study and found no statistically significant effects on utilization rates and robust null effects on health outcomes, including child mortality [38]. However, some positive impacts on treatment quality and patient satisfaction were identified [38]. The Transparency for Development study reported that a community-led transparency and accountability programme to improve maternal and newborn health did not have a statistically significant impact on the use or content of the services, nor on perceptions of civic efficacy or civic participation among recent mothers in the communities where it was offered [39].

Several reasons have been postulated to explain the lack of evidence on health outcomes and outcomes specific to contraceptive service provision. Methodological challenges have been identified in researching SA processes as it varies from context to context and entails multiple and interrelated components, steps and actors and several simultaneous behaviour change processes [40]. Quantitative or clinical study designs that reduce or attempt to control the complexity of SA may lead to several dimensions, such as political factors and power dynamics, being missed [41]. This emphasizes the importance of applying a complex designed methodology to account for the multiple components, including a process evaluation with context evaluation to track the different levels and interrelated outcomes of SA [22, 40].

Strengths of the study

We used a quasi-experimental design with a control group as randomization was not feasible in this project. A control group is essential to ascertain that the reported findings are attributable to the intervention. An ITS-CG design was used in this quasi-experimental design to evaluate the effectiveness of the intervention to show the accelerating uptake of modern contraceptives [25]. The strength of this segmented ITS modeling is that it can demonstrate the effect of an intervention on the number or the trend in uptake of modern contraceptives. ITS-design accounts for time and allows non-parallel trends between the two groups [42]. It also addresses varying durations of intervention roll-out and delayed effects of the intervention, which are characteristic of SA processes [25, 43]. Other advantages include minimizing a history bias by allowing for both the before-after intervention comparison and the intervention-control group comparison to be made [44].

The contraceptive uptake outcome reported here should be interpreted with other CaPSAI outcomes, such as the intermediate outcomes, case studies of change, and the process evaluation, including context mapping – these will be reported in detail elsewhere.

The CaPSAI Project followed the MRC guidance of studying complex interventions and incorporated SA intermediate outcome measures and an extensive process evaluation [20]. Triangulating the process evaluation findings, intermediate outcome measures, and the health outcomes evaluated by CaPSAI could allow us to gain a fuller picture and unpack the causal pathways. Intermediate outcomes of SA and the changes at the facility level, as depicted by case studies of change, were shown to affect service delivery and at the community level in the CaPSAI Project. Previous studies have shown positive results on these levels of outcomes in both RMNCAH and contraceptive service provision (Appendix). CaPSAI validated psychometric scales were used to measure SA outcomes such as women'sFootnote 1 acknowledgment and awareness of rights, empowerment and self-efficacy, and participation in collective action [20, 45]. Throughout the study, the researchers also tracked the stories of change which are transformations at the facility level directly stemming from the prioritizations and joint action planning done as part of the intervention [20]. Selected case studies were verified through document review and IDI with key informants. These case studies provide a better understanding of how the changes occurred and describe the context and factors that enabled them.

The process evaluation's main aim was to document the implementation of the intervention and understand whether this was done as intended and whether it reached the target audiences. It also documented the facilitators and barriers to the intervention [20]. In a previously published process evaluation of a community monitoring programme initiated by a national health body, the authors were able to evaluate the quality of activities conducted, the level of community participation and engagement with health providers, and identify the gaps in the implementation [46].

The process evaluation also included context mapping, which was conducted at baseline and on a yearly basis throughout the study period (Steyn 2020). Specifically, the objectives were to gauge the types of family planning promotion done at the community level and whether there were participatory activities done that may have affected the intervention or the rates of contraceptive uptake in both the intervention and control groups, and how these changed over time. Understanding how SA initiatives interact or are influenced by contextual factors has been underlined in the existing literature. Examining the different types of actors, political or civil society systems, and the relationships between them can support the development of context-sensitive theories of change when adapting or replicating SA to different contexts [47] and identify and account for the enabling environment and constraints for SA [48]. SA exists in complex ecosystems that may include other accountability mechanisms that may have implications on how a SA process functions and is perceived [49]. Contextual factors and influences have shown how the synergistic influences of the individual, spousal, organizational, and societal factors that influence individual preferences but also constrain how individuals implement them [50].

Country context

The findings of the context mapping conducted in the intervention and control districts in both Ghana and Tanzania will be reported elsewhere. Here, we report the contextual factors identified in published literature and other studies on participatory processes in the two settings. Various family planning interventions have been implemented in Ghana over the years (e.g., [51, 52]). However, nationally representative data from 2017 indicate that since 2003, the mCPR rate among married women has increased by a mere six percentage points to 25%, and unmet need has remained at an average of 30% over the same period [28]. Specific to Central region, mCPR increased from 13% in 2003 [27] to 28% in 2014 [29] and declined to 25% in 2017 [28]. Unmet need for contraception in the region decreased from 50% in 2003 [27] to 29% in 2014 [29]. Reasons for use and non-use continue to be studied and vary depending on context. Place of residence, educational level [53, 54], marital status, partner consent and support, religious beliefs [55], and age [56] have all been identified as determinants of contraceptive use. At the same time, fear of side effects, concern with the menstrual irregularities caused by hormonal methods, myths, and misconceptions have been cited as reasons for non-use [56, 57]. An evaluation of a personalized, community-based counseling and referral programme on modern contraceptive use in selected urban areas of Ghana found that the intervention did not achieve its aim to reach all reproductive-aged women in the community, and there was no significant effect of the intervention at either programme close or two years later [52]. Another study on the long-term impact of the Navrongo project in Northern Ghana, which included social mobilization activities, found a significant fertility decline arose in the project's early years [51].

The finding on uptake could be explained by the steady but slow increase in the use of modern contraceptives in Tanzania regardless the number of nationally implemented efforts which are nationally implemented. A recent study [58], conducted in Tanzania found that the overall use of modern contraceptives has increased only by 11.3 percent, that is 20.0% in 2004/2005 to 32% in 2015/2016. The national target of 45% mCPR by 2020 was not achieved [58]. An example of national-level efforts made includes the publication of the National Family Planning Costed Implementation Program 2010–2015, which targeted a national CPR of 60% by 2015. The National Family Planning Research Agenda was also updated to identify gaps in family planning through evidence-based knowledge. The One Plan II was launched, aiming to achieve a national mCPR of 45%, reduce the unmet need of contraception to 10% by 2020 and double the number of family planning users to 4.3 million by 2020 as part of family planning 2020 initiatives. The use of modern contraceptives in Tanzania is not uniform. It varies due to individual and regional determinants. A study [59] conducted in Tanzania proposed that contraceptive use increases with household wealth and with an increasing number of children ever born. Further, it was identified that in Tanzania, women who live in urban areas and who see community-based distribution workers and clinic staff as the primary people to talk about family planning are more likely than other women to use contraceptives. Education level has been identified as an important factor influencing contraceptive use and may vary at the regional level [59,60,61,62].

Limitations of the study

The CaPSAI Social Accountability intervention was delivered in contexts where many other interventions were happening in both groups. Specific outreach programmes (e.g., awareness campaigns and specific days to insert subcutaneous implants, policy, and political changes) may have affected community or provider behaviour towards contraception and contraceptive use. History bias occurred as non-study interventions and other activities affecting modern contraceptive uptake were implemented during the roll-out of the study intervention. In Tanzania, we identified that outreach activities were being included in facility data. This could have affected our facility selection process as one of the selection criteria was that facilities had to have at least 50 new users per month on average. Ongoing outreach activities are captured and will be reported elsewhere. The existence of multiple programmes to improve family planning and contraceptive service provision can lead to synergies resulting in the integration of activities [13]. However, these need to be considered when designing programmes and evaluating the impact.

A limitation of ITS-CG is that it does not account for the lack of intervention coverage and depends on whether the intervention is rolled-out to the facilities and respective catchment communities. Another limitation is dose–response, defined as the degree of completeness of the reforms deemed necessary by the community at the end of step 6. The degree of completeness and quality of reforms may influence community satisfaction and uptake of modern contraception when the post-intervention assessment was done. The models cannot account for this dose–response scenario nor the variation in satisfaction levels between communities receiving the intervention. The case studies of change conducted as part of CaPSAI will shed some light on whether prioritized issues have been addressed and in what quality. Seasonal autocorrelation could also not be accounted for in the model for the CaPSAI study since it requires minimum of 24 monthly data points, distributed on the same calendar month at pre- and post-intervention [43].

Study designs using longer time series observations have been shown to be reliable in estimating the effect of the interventions and can robustly model the underlying trends, changes, and random fluctuations [25, 43, 63]. In CaPSAI, we used a shorter time series design with ten pre-intervention and 18 post-intervention observations. Shorter time-series designs are still being used as they are considered more feasible, less resource-intensive than more extended time series, and are used primarily when the interest is in the assessment of the effectiveness of an intervention during a limited period [25]. Multiple rounds of the intervention and a longer follow-up may have shown statistical significance.

A control group for the ITS-CG design must be chosen carefully [42] to ensure baseline comparability to the intervention group. Efforts were made to achieve covariate balance at baseline by considering key characteristics of facilities and catchment areas (rural and urban, level of facility, average number of new users per facility). However, there may have been key differences that could not be accounted for during site selection.


The data did not show a statistically significant increase in uptake of contraceptives using new users as an indicator for an intervention of six months. In evaluating the impact of the intervention results on intermediate outcomes such as self-efficacy among service users, trust and countervailing power among social groups/networks, and responsiveness of service providers, cases of change and process evaluation should be considered.

This SA intervention was delivered in the context of numerous other interventions addressing the same outcomes that may affect the study's power, i.e., specific outreach programmes. Process evaluation and reach of these programmes are important to contextualize the results.

There is a need for further research on the impact of SA, including evaluating changes in attitudes, behaviour, and experiences of providers, users, and social groups. Experimental designs to understand potential links between SA and service utilization should include counterfactual analysis and be supported by structured process evaluation.

Availability of data and materials

The de-identified dataset used and/or analysed during the current study can be requested from the Primary Sponsor or Principal Investigators, and data will be shared contingent on approval by the internal review and approval by local internal ethics review board.


  1. A health provider survey to measure social accountability intermediate outcomes was also used in CaPSAI but as the psychometric scales were not validated, we will not be reporting on the results.



Community and Provider driven Social Accountability Intervention


Civil Society Organizations


Generalized Estimating Equation


In-depth interviews


Interrupted time series design with a control group


Low- and middle-income countries


Medical Research Council


Modern contraceptive prevalence rate


Reproductive, maternal, newborn and child, and adolescent health


Social accountability


Sexual and Reproductive Health and Rights


Theory of change


  1. Sully E, Biddlecom A, Darroch JE, Riley T, Ashford LS, Lince-Deroche N, Firestein L, Murro R. Adding it up: investing in sexual and reproductive health 2019. New York: Guttmacher Institute; 2020. .

  2. United Nations – Population division. Sustainable Development Goals. DG Indicator 3.7.1 on Contraceptive Use; 2015. Accessed on 5 July 2021.

  3. United Nations. World Fertility and Family Planning 2020: Highlights. New York: United Nations; 2020.

    Google Scholar 

  4. Kantorová V, Wheldon MC, Dasgupta AN, Ueffing P, Castanheira HC. Contraceptive use and needs among adolescent women aged 15–19: Regional and global estimates and projections from 1990 to 2030 from a Bayesian hierarchical modelling study. PLoS ONE. 2021;16(3):e0247479.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ahinkorah BO. Predictors of unmet need for contraception among adolescent girls and young women in selected high fertility countries in sub-Saharan Africa: A multilevel mixed effects analysis. PLoS ONE. 2020;15(8):e0236352.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. World Health Organization. "Ensuring human rights within contraceptive programmes: a human rights analysis of existing quantitative indicators." Geneva: World Health Organization; 2014.

  7. United Nations Secretary General Ban Ki-moon. Global Strategy for Women’s and Children’s Health. San Francisco: Health; 2010.

    Google Scholar 

  8. Squires F, Martin Hilber A, Cordero JP, Boydell V, Portela A, Lewis Sabin M, Steyn P. Social accountability for reproductive, maternal, newborn, child and adolescent health: A review of reviews. PLoS ONE. 2020;15(10):e0238776.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Boydell V, Keesbury J. Social accountability: What are the lessons for improving family planning and reproductive health programs? Working paper. Washington, DC: Population Council, Evidence Project; 2014. Accessed on 23 Sept 2021.

    Book  Google Scholar 

  10. Steyn PS, Cordero JP, Gichangi P, Smit JA, Nkole T, Kiarie J, Temmerman M. Participatory approaches involving community and healthcare providers in family planning/contraceptive information and service provision: a scoping review. Reprod Health. 2016;13(1):1–3.

    Article  Google Scholar 

  11. Joshi A. Legal Empowerment and Social Accountability: Complementary Strategies Toward Rights-based Development in Health? World Dev. 2017;99:160–72.

    Article  Google Scholar 

  12. Sebert Kuhlmann AK, Altman L, Galavotti C. The importance of community mobilization in interventions to improve sexual, reproductive, and maternal health outcomes: A review of the evidence. Health Care Women Int. 2016;37(10):1028–66.

    Article  PubMed  Google Scholar 

  13. Boydell V, Neema S, Wright K, Hardee K. Closing the gap between people and programs: lessons from implementation of social accountability for family planning and reproductive health in Uganda. Afr J Reprod Health. 2018;22(1):73–84.

    PubMed  Google Scholar 

  14. Boydell V, Nulu N, Hardee K, Gay J. Implementing social accountability for contraceptive services: lessons from Uganda. BMC Womens Health. 2020;20(1):1–2.

    Article  Google Scholar 

  15. Hamal M, de Cock BT, De Brouwere V, Bardají A, Dieleman M. How does social accountability contribute to better maternal health outcomes? A qualitative study on perceived changes with government and civil society actors in Gujarat. India BMC health services research. 2018;18(1):1–5.

    Google Scholar 

  16. Otchere S, Jacob V, Toppo AA, Massey A, Samson S. Social accountability and education revives health sub-centers in India and increases access to family planning services. Christian J Global Health. 2017;4(2):10–8.

    Article  Google Scholar 

  17. Panthi GP. Social Accountability for Adolescent Sexual and Reproductive Health. Himalayan J Sociol Anthropol. 2016;7:13–39.

    Article  Google Scholar 

  18. Gullo S, Galavotti C, Altman L. A review of CARE’s community score card experience and evidence. Health Policy Plan. 2016;31(10):1467–78.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Gullo S, Galavotti C, Sebert Kuhlmann A, Msiska T, Hastings P, Marti CN. Effects of the Community Score Card approach on reproductive health service-related outcomes in Malawi. PLoS ONE. 2020;15(5):e0232868.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Steyn PS, Boydell V, Cordero JP, McMullen H, Habib N, Nguyen TM, Nai D, Shamba D, Kiarie J, Project C. Rationale and design of a complex intervention measuring the impact and processes of social accountability applied to contraceptive programming: CaPSAI Project. Gates Open Res. 2020;4:26.

    Article  PubMed  PubMed Central  Google Scholar 

  21. McMullen H, Boydell V, Cordero JP, Steyn PS, Kiarie J, Kinemo P, Monyo A, Addah MA, Ahuno JT, Gyamfi OB. Accounting for complexity–Intervention design in the context of studying social accountability for reproductive health. Gates Open Res. 2021;5(107):107.

    Article  PubMed  Google Scholar 

  22. Moore G, Audrey S, Barker M, et al. Process evaluation of complex interventions: a summary of Medical Research Council guidance. In: Richards D, Hallberg IR, editors., et al., Complex interventions in health: an overview of research methods. Abingdon: Routledge; 2015.

    Google Scholar 

  23. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;29:337.

    Google Scholar 

  24. Cordero JP, Steyn PS, Gichangi P, Kriel Y, Milford C, Munakampe M, Njau I, Nkole T, Silumbwe A, Smit J, Kiarie J. Community and provider perspectives on addressing unmet need for contraception: key findings from a formative phase research in Kenya, South Africa and Zambia (2015–2016). Afr J Reprod Health. 2019;23(3):106–19.

    PubMed  PubMed Central  Google Scholar 

  25. Habib N, Steyn PS, Boydell V, Cordero JP, Nguyen MH, Thwin SS, Nai D, Shamba D, Kiarie J. The use of segmented regression for evaluation of an interrupted time series study involving complex intervention: the CaPSAI project experience. Health Serv Outcomes Res Method. 2021;21(2):188–205.

    Article  Google Scholar 

  26. Steyn PS, Boydell V, Cordero JP, Habib HM, Nai N, Shamba D, Kiarie DJ. Community and provider driven social accountability intervention (CaPSAI) project: study protocol. 2019. Accessed on 5 Jul 2021.

  27. Ghana Statistical Service (GSS), Noguchi Memorial Institute for Medical Research (NMIMR) and ORC Macro. Ghana Demographic and Health Survey 2003. Calverton, Maryland: GSS, NMIMR, and ORC Macro; 2004.

    Google Scholar 

  28. Ghana Statistical Service (GSS), Ghana Health Service (GHS), and ICF. Ghana Maternal Health Survey 2017. Accra, Ghana: GSS, GHS, and ICF; 2018.

    Google Scholar 

  29. Ghana Statistical Service (GSS), Ghana Health Service (GHS), and ICF International. Ghana Demographic and Health Survey 2014. Rockville, Maryland, USA: GSS, GHS, and ICF International; 2015.

    Google Scholar 

  30. Ghana Statistical Service. Multiple Indicator Cluster Survey (MICS2017/18), Survey Findings Report. Accra, Ghana: GSS; 2018.

    Google Scholar 

  31. National Bureau of Statistics (NBS) Tanzania and ICF Macro. Tanzania Demographic and Health Survey 2010. Dar es Salaam, Tanzania: NBS and ICF Macro; 2011.

    Google Scholar 

  32. Ministry of Health, Community Development, Gender, Elderly and Children (MoHCDGEC) [Tanzania Mainland], Ministry of Health (MoH) [Zanzibar], National Bureau of Statistics (NBS), Office of the Chief Government Statistician (OCGS), and ICF. Tanzania Demographic and Health Survey and Malaria Indicator Survey (TDHS-MIS) 2015–16. Dar es Salaam, Tanzania, and Rockville, Maryland, USA: MoHCDGEC, MoH, NBS, OCGS, and ICF; 2016.

    Google Scholar 

  33. Zhang F, Wagner AK, Ross-Degnan D. Simulation-based power calculation for designing interrupted time series analyses of health policy interventions. J Clin Epidemiol. 2011;64(11):1252–61.

    Article  PubMed  Google Scholar 

  34. Steyn, Petrus S; Boydell, Vicky; Cordero, Joanna; McMullen, Heather; Habib, Ndema; Shamba, Donat; et al. CaPSAI Project - Extended Data: Facility audit (FAU). figshare. 2020. Online resource.

  35. World Health Organization. Service availability and readiness assessment (SARA): an annual monitoring system for service delivery: Reference Manual, Version 2.2. Geneva: World Health Organization; 2015.

  36. CaPSAI Project Team, CaPSAI Project - Standard Operating Procedures: Standard Operating Procedure for Double Data Entry using OpenClinica. figshare. 2021. Online resource.

  37. Björkman M, Svensson J. Power to the people: evidence from a randomized field experiment on community-based monitoring in Uganda. Q J Econ. 2009;124(2):735–69.

    Article  Google Scholar 

  38. Raffler P, Posner DN, Parkerson D. The weakness of bottom-up accountability: experimental evidence from the Ugandan health sector. Los Angeles: Innovations for Poverty Action; 2019.

    Google Scholar 

  39. Arkedis J, Creighton J, Dixit A, Fung A, Kosack S, Levy D, Tolmie C. Can transparency and accountability programs improve health? Experimental evidence from Indonesia and Tanzania. World Dev. 2021;1(142):105369.

    Article  Google Scholar 

  40. Boydell V, McMullen H, Cordero J, Steyn P, Kiare J. Studying social accountability in the context of health system strengthening: innovations and considerations for future work. Health Res Policy Syst. 2019;17(1):1–6.

    Article  Google Scholar 

  41. Marston C, McGowan CR, Boydell V, Steyn P. Methods to measure effects of social accountability interventions in reproductive, maternal, newborn, child, and adolescent health programs: systematic review and critique. J Health Popul Nutr. 2020;39(1):1–25.

    Article  Google Scholar 

  42. Lopez Bernal J, Cummins S, Gasparrini A. Difference in difference, controlled interrupted time series and synthetic controls. Int J Epidemiol. 2019;48(6):2062–3.

    Article  PubMed  Google Scholar 

  43. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299–309.

    Article  CAS  PubMed  Google Scholar 

  44. Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348–55.

    PubMed  Google Scholar 

  45. Boydell V, Steyn PS, Cordero JP, Habib N, Nguyen MH, Nai D, Shamba D. Adaptation and validation of social accountability measures in the context of contraceptive services in Ghana and Tanzania. Int J Equity Health. 2020;19(1):1–23.

    Article  Google Scholar 

  46. Tripathy JP, Aggarwal AK, Patro BK, Verma H. Process evaluation of community monitoring under national health mission at Chandigarh, union territory: Methodology and challenges. J Fam Med Primary Care. 2015;4(4):539.

    Article  Google Scholar 

  47. O'Meally SC. Mapping context for social accountability: a resource paper. World Bank, Washington, DC. © World Bank.2013.License: CC BY-NC-ND 3.0 IGO Accessed on 29 Aug 2021.

  48. Mafuta EM, Hogema L, Mambu TN, Kiyimbi PB, Indebe BP, Kayembe PK, Buning TD, Dieleman MA. Understanding the local context and its possible influences on shaping, implementing and running social accountability initiatives for maternal health services in rural Democratic Republic of the Congo: a contextual factor analysis. BMC Health Serv Res. 2016;16(1):1–3.

    Article  Google Scholar 

  49. Mukinda FK, Van Belle S, George A, Schneider H. The crowded space of local accountability for maternal, newborn and child health: a case study of the South African health system. Health Policy Plan. 2020;35(3):279–90.

    Article  PubMed  Google Scholar 

  50. Rusibamayila A, Phillips J, Kalollela A, Jackson E, Baynes C. Factors influencing pregnancy intentions and contraceptive use: an exploration of the ’unmet need for family planning’in Tanzania. Cult Health Sex. 2017;19(1):1–6.

    Article  PubMed  Google Scholar 

  51. Phillips JF, Jackson EF, Bawah AA, MacLeod B, Adongo P, Baynes C, Williams J. The long-term fertility impact of the Navrongo Project in Northern Ghana. Stud Fam Plann. 2012;43(3):175–90.

    Article  PubMed  Google Scholar 

  52. Henry EG, Hackett KM, Bawah A, Asuming PO, Agula C, Canning D, Shah I. The impact of a personalized, community-based counselling and referral programme on modern contraceptive use in urban Ghana: a retrospective evaluation. Health Policy Plan. 2020;35(10):1290–9.

    Article  PubMed Central  Google Scholar 

  53. Aviisah PA, Dery S, Atsu BK, Yawson A, Alotaibi RM, Rezk HR, Guure C. Modern contraceptive use among women of reproductive age in Ghana: analysis of the 2003–2014 Ghana Demographic and Health Surveys. BMC Women’s Health. 2018;20(18):141.

    Article  Google Scholar 

  54. Adanu RMK, Darko R, Seffah JD, Hill AG, Duda RB, Anarfi JK. Contraceptive use by women in Accra, Ghana: results from the 2003 Accra Women’s Health Survey. Afr J Reprod Health. 2009;13(1):123–33.

    PubMed  Google Scholar 

  55. Beson P, Appiah R, Adomah-Afari A. Modern contraceptive use among reproductive-aged women in Ghana: prevalence, predictors, and policy implications. BMC Womens Health. 2018;18(1):157.;PMCID:PMC6156857.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Keogh SC, Otupiri E, Castillo PW, Chiu DW, Polis CB, Nakua EK, Bell SO. Hormonal contraceptive use in Ghana: The role of method attributes and side effects in method choice and continuation. Contraception. 2021;104(3):235–45. (Epub 2021 May 14 PMID: 33992609).

    Article  PubMed  Google Scholar 

  57. Hindin MJ, McGough LJ, Adanu RM. Misperceptions, misinformation and myths about modern contraceptive use in Ghana. J Fam Plann Reprod Health Care. 2014;40(1):30–5. (Epub 2013 Jun 15 PMID: 23771916).

    Article  PubMed  Google Scholar 

  58. Yussuf MH, Elewonibi BR, Rwabilimbo MM, Mboya IB, Mahande MJ. Trends and predictors of changes in modern contraceptive use among women aged 15–49 years in Tanzania from 2004–2016: evidence from Tanzania demographic and health surveys. PLoS ONE. 2020;15(6):e0234980.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Anasel MG, Haisma H. Variation in contraceptive prevalence rates in Tanzania: A multilevel analysis of individual and regional determinants. Sex Reprod Healthc [Internet]. 2020;25(April):100517.

    Article  PubMed  Google Scholar 

  60. Msoffe GEP, Kiondo E. Accessibility and use of family planning information (FPI) by rural people in Kilombero District, Tanzania. African J Libr Arch Inf Sci. 2009;19(2):117–27.

    Google Scholar 

  61. L’Engle KL, Vahdat HL, Ndakidemi E, Lasway C, Zan T. Evaluating feasibility, reach and potential impact of a text message family planning information service in Tanzania. Contraception. 2013;87(2):251–6.

    Article  PubMed  Google Scholar 

  62. Tengia-Kessy A, Rwabudongo N. Utilization of modern family planning methods among women of reproductive age in a rural setting: the case of Shinyanga rural district, Tanzania. East Afr J Public Heath. 2006;3(2):26–30.

    Google Scholar 

  63. Shadish W, Cook T, Campbell D. Experimental and Quasi-Experimental Designs for Generalized Causal Inference. Boston: Houghton Mifflin; 2002.

    Google Scholar 

  64. Baloch GM, Ali M. Community Monitoring in Reproductive Health Projects: Case Study of a Health Sector NGO in Pakistan. VFAST Transact Educ Soc Sci. 2015;3(1):175–82.

    Google Scholar 

  65. Blake C, Annorbah-Sarpei NA, Bailey C, Ismaila Y, Deganus S, Bosomprah S, Galli F, Clark S. Scorecards and social accountability for improved maternal and newborn health services: a pilot in the Ashanti and Volta regions of Ghana. Int J Gynecol Obstet. 2016;135(3):372–9.

    Article  Google Scholar 

  66. Ekirapa-Kiracho E, Namuhani N, Apolot RR, Aanyu C, Mutebi A, Tetui M, Kiwanuka SN, Ayen FA, Mwesige D, Bumbha A, Paina L. Influence of community scorecards on maternal and newborn health service delivery and utilization. Int J Equity Health. 2020;19(1):1–2.

    Google Scholar 

  67. Nove A, Hulton L, Martin-Hilber A, Matthews Z. Establishing a baseline to measure change in political will and the use of data for decision-making in maternal and newborn health in six African countries. Int J Gynecol Obstet. 2014;127(1):102–7.

    Article  Google Scholar 

  68. Dasgupta J, Sandhya YK, Lobis S, Verma P, Schaaf M. Using technology to claim rights to free maternal health care: lessons about impact from the my health, my voice pilot project in India. Health Hum Rts J. 2015;17:135.

    Google Scholar 

  69. Balestra GL, Dasgupta J, Sandhya YK, Mannell J. Developing political capabilities with community-based monitoring for health accountability: the case of the Mahila Swasthya Adhikar Manch. Glob Public Health. 2018;13(12):1853–64.

    Article  PubMed  Google Scholar 

  70. Ray S, Madzimbamuto F, Fonn S. Activism: working to reduce maternal mortality through civil society and health professional alliances in sub-Saharan Africa. Reprod Health Matters. 2012;20(39):40–9.

    Article  PubMed  Google Scholar 

  71. Hulton L, Matthews Z, Martin-Hilber A, Adanu R, Ferla C, Getachew A, Makwenda C, Segun B, Yilla M. Using evidence to drive action: A “revolution in accountability” to implement quality care for better maternal and newborn health in Africa. Int J Gynecol Obstet. 2014;127(1):96–101.

    Article  Google Scholar 

  72. Pandey P, Sehgal AR, Riboud M, Levine D, Goyal M. Informing resource-poor populations and the delivery of entitled health and social services in rural India: a cluster randomized controlled trial. JAMA. 2007;298(16):1867–75.

    Article  CAS  PubMed  Google Scholar 

  73. World Vision. Citizen Voice and Action: An effective local level advocacy approach to increase local government accountability. 2012. Accessed on 23 September 2021.

  74. Ekirapa-Kiracho E, Namazzi G, Tetui M, Mutebi A, Waiswa P, Oo H, Peters DH, George AS. Unlocking community capabilities for improving maternal and newborn health: participatory action research to improve birth preparedness, health facility access, and newborn care in rural Uganda. BMC Health Serv Res. 2016;16(7):93–104.

    PubMed Central  Google Scholar 

  75. Gullo et. al. CARE's experience with community score cards: what works and why? Synthesis Report. London: Overseas Development Institute; 2015.

  76. Papp SA, Gogoi A, Campbell C. Improving maternal health through social accountability: A case study from Orissa. India Global public health. 2013;8(4):449–64.

    Article  PubMed  Google Scholar 

  77. Kim YM, et al. Final evaluation of the project for expanding the role of networks of people living with HIV/AIDS: Final report. New York: Population Council; 2009.

    Book  Google Scholar 

  78. Hargreaves JR, Goodman C, Davey C, Willey BA, Avan BI, Schellenberg JR. Measuring implementation strength: lessons from the evaluation of public health strategies in low-and middle-income settings. Health Policy Plan. 2016;31(7):860–7.

    Article  PubMed  PubMed Central  Google Scholar 

  79. George AS, Mohan D, Gupta J, LeFevre AE, Balakrishnan S, Ved R, Khanna R. Can community action improve equity for maternal health and how does it do so? Research findings from Gujarat, India. Int J Equity Health. 2018;17(1):1–1.

    Article  Google Scholar 

  80. Manandhar DS, Osrin D, Shrestha BP, Mesko N, Morrison J, Tumbahangphe KM, Tamang S, Thapa S, Shrestha D, Thapa B, Shrestha JR. Effect of a participatory intervention with women’s groups on birth outcomes in Nepal: cluster-randomised controlled trial. The Lancet. 2004;364(9438):970–9.

    Article  Google Scholar 

Download references


In Ghana, the authors would like to acknowledge the Ministry of Health, Ghana Health Service as well as regional and district health authorities of Central region. The authors thank all the study participants in all study districts, the whole team of research assistants and all the people involved in the study. Authors would also like to acknowledge the support of colleagues from Population Council Ghana and New York (Augustine Ankomah, Michelle Hindin, Rachel Narki Anum, Kojo Mensah Sedzro, Martin Agbodzi, Seth Boateng and Emmanuel Amevor).

In Tanzania, the authors would like to acknowledge participating district health authorities and regional medical officers for their support throughout the study. The authors thank all study participants in all study districts, the whole team of research assistants and all the people involved in the study. Authors would also like to acknowledge the support of the Chief Executive Director of Ifakara Health Institute, Honorati Masanja, the CaPSAI data manager in Tanzania, Selemani Mmbaga and the IHI administrative team (Catherine Ringo, Adeline Herman, Doreen Philemon, and Pamela Sao). This manuscript is published with permission from the National Institute for Medical Research and the Director of Ifakara Health Institute – Tanzania.

The authors would also like to acknowledge CaPSAI Project implementation lead, Victoria Boydell (independent) and implementation team members, Mary Awelana Addah and Osei-Bonsu Gyamfi from Ghana Integrity Initiative, Ghana; Alice Monyo, Happy Myovela and Joshua Nkila from Sikika, Tanzania. Implementation support was provided by Heather McMullen (Queen Mary University) and Vernon Mochache (independent).

Additional analytical input was provided by Soe Soe Thwin (WHO) and data management support was provided by Antonio-Lucio Fersurella (WHO). Additional conceptual input on the CaPSAI protocol was provided by Ian Askew (WHO) and Karen Hardee (Evidence Project). The CaPSAI Project team would also like to acknowledge the support of Roseline Doe and Edwin Swai from the WHO country offices in Ghana and Tanzania, respectively.

Author information

Authors and Affiliations



PSS, JPC and JK contributed to the conception of the study. PSS, JPC, NH, MHN and JK contributed in the design of the protocol. DN, DS, KF, SM, MHN were responsible for data acquisition. MHN created the software used in the work. All authors contributed in the analysis and interpretation of data. Drafting was done by PSS and JPC and all authors substantially contributed in the review, revision and finalisation of the manuscript. All authors approved the submitted version. All agree to be personally accountable for their own contributions and to ensure that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature.

Authors’ information

The authors alone are responsible for the views expressed in this article, and they do not necessarily represent the views, decisions or policies of the institutions with which they are affiliated.

Corresponding author

Correspondence to Petrus S. Steyn.

Ethics declarations

Ethics approval and consent to participate

The protocol was approved by the Research Project Review Panel, the (RP2), the scientific review panel in the Department of Sexual and Reproductive Health and Research in WHO, as well as the WHO Ethics Review Committee (ERC) as a master protocol (A 658996), as well as two context-specific protocols (A 658996_Ghana and A 658996_Tanzania). The protocol is registered with the Australian New Zealand Clinical Trials registry (ACTRN12619000378123). Local context-specific protocols were approved in the country and institutional Ethics research bodies. In Ghana, the protocol was approved by the Ghana Health Service ERC (GHS-ERC:009/08/17). The Population Council Institutional Review Board waived the review of the protocol based on WHO ERC approval. The Ministry of Health and Ghana Health Service also provided administrative approvals for the study. Permission was also sought from leaders of intervention communities. In Tanzania, the protocol was approved by Ifakara Health Institute – Institutional Review Board, Mbeya Medical Research and Ethics Review Committee Secretariat and Medical Research Coordinating Committee of the National Institute for Medical Research with approval number IHI/IRB/No:18–2017, Ref No. GB.152/377/01/214a and NMR/HQ/R.8a/Vol. IX/2668 respectively. The study also received a commitment letter with reference number Na. AB.307/323/01 from the Ministry of President Office Regional Administration and Local Government to implement the study in the local communities of Mbeya and Iringa regions.

The facility audit was conducted by telephone or in person at the facility and data were obtained from the person in charge of family planning services and facility documentation. It was not required to obtain consent before conducting interviews.

Consent for publication

Not applicable.

Competing interests

The authors did not declare any competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.



Table 6.

Table 6 Reported outcomes related to RMNCAH and family planning and contraceptive service provision

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Steyn, P.S., Cordero, J.P., Nai, D. et al. Impact of community and provider-driven social accountability interventions on contraceptive uptake in Ghana and Tanzania. Int J Equity Health 21, 142 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: